All In MedTech

Device Trial Radar · NCT05491070

Comparison of Different Vascular Closure Device in TAVI

Efficacy Comparison of Different Femoral Vascular Closure Method Following Percutaneous Transcatheter Aortic Valve Implantation

Last checked: Nov 20, 2026Latest source record: Sep 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 260 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

260

Actual

Start

Mar 20, 2018

Primary completion

Apr 13, 2023

Study completion Apr 30, 2024

Sponsor

Lead sponsor
National Taiwan University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 8, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Femoral artery approach for transcatheter aortic valve implantation (TAVI) is an ideal approach site. However the closure for femoral artery after transfemoral TAVI is challenging. We aimed to compared the efficacy and safety of Angio-Seal + Proglide vs. Dual Proglide for femoral arteriotomy closure following TAVI

Conditions

  • Aortic Valve Stenosis
  • Transcatheter Aortic Valve Implantation

Interventions

  • Vascular closure device (Angio-Seal, Progilde)Device

    In transfemoral TAVI, vascular closure devices were used for femoral artery wound closure, progilde and angio-seal can be used in wound closure. We aimed to compared the efficacy and safety of different vascular closure device in TAVI

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Vascular complicationTime frame: during hospitalization for index procedure
  2. Life threatening bleeding complicationTime frame: within 24hrs after the index procedure
  3. Major or minor bleeding complication without life threatening conditionTime frame: within 24hrs after the index procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Taiwan University Hospital

    Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.